These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1302841)

  • 1. [UV-irradiation of the blood in the treatment of polycystic ovary syndrome].
    Kalinin AP; Makeev SA; Tyshenina RS
    Probl Endokrinol (Mosk); 1992; 38(6):19-21. PubMed ID: 1302841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
    Taylor AE; McCourt B; Martin KA; Anderson EJ; Adams JM; Schoenfeld D; Hall JE
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma follicle-stimulating and luteinizing hormones and the macrosopic characteristics of the ovaries in patients with stein-leventhal syndrome. Response to LH-RH in Stein-Leventhal syndrome.
    Valkov IM; Dokumov I
    Endocrinologie; 1977; 15(1):55-8. PubMed ID: 322249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.
    Banaszewska B; Spaczyński RZ; Pelesz M; Pawelczyk L
    Rocz Akad Med Bialymst; 2003; 48():131-4. PubMed ID: 14737959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inappropriate gonadotropin secretion in the polycystic ovary syndrome].
    Pilotti L; Data PG; Di Tano G
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1885-90. PubMed ID: 6440582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the hypothalamic origin of the polycystic ovary syndrome.
    Wortsman J; Singh KB; Murphy J
    Obstet Gynecol; 1981 Aug; 58(2):137-41. PubMed ID: 6454866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the antiserotoninergic preparation cyproheptadine on the levels of luteinizing and follicle-stimulating hormones and testosterone in patients with polycystic ovaries].
    Tudose TI
    Probl Endokrinol (Mosk); 1987; 33(3):22-5. PubMed ID: 3116528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant?
    Milsom SR; Sowter MC; Carter MA; Knox BS; Gunn AJ
    BJOG; 2003 Aug; 110(8):760-4. PubMed ID: 12892688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of Polycystic Ovaries by Estrogen Therapy.
    Gambrell RD
    Obstet Gynecol; 1976 May; 47(5):569-74. PubMed ID: 131262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of basal serum luteinizing hormone and luteinizing hormone/follicle-stimulating hormone ratio on outcomes of in vitro fertilization-embryo transfer in patients with polycystic ovarian syndrome].
    Geng X; Ou X; Liao Y; Tan W; Wang S; Quan S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):857-60. PubMed ID: 23803197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone profile & polycystic ovaries in acne vulgaris.
    Jebraili R; Kaur S; Kanwar AJ; Kataria S; Dash RJ
    Indian J Med Res; 1994 Aug; 100():73-6. PubMed ID: 7927560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum LH and FSH levels in women with polycystic ovary syndrome before and after ovarian wedge resection.
    Shterev AD; Dokumov SI
    Endocrinologie; 1982; 20(3):203-7. PubMed ID: 6815773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of synthetic gonadotropin releasing hormone on the plasma levels of FH and LSH in women with hirsutism and polycystic ovaries].
    Pjević M; Kovac T; Bujas M; Pusac R
    Jugosl Ginekol Perinatol; 1985; 25(3-4):49-52. PubMed ID: 3938829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA; Shin SY; Yoon BK; Choi D
    Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of ultraviolet irradiation of the blood on various hormonal indicators in women with sclerocystic ovaries].
    Makeev SA; Tishenina RS; Anashkina GA
    Sov Med; 1990; (3):98-100. PubMed ID: 2367912
    [No Abstract]   [Full Text] [Related]  

  • 20. [Circulating levels of LH, FSH and basal steroids in subjects with polycystic ovary syndrome before and after wedge resection of the ovaries].
    Ragucci N; Amato G; Izzo A
    Arch Ostet Ginecol; 1981; 86(5-6):263-79. PubMed ID: 6819842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.